References
- 1. Lubeck PR, Doerr HW, Rabenau HF. Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol. 2010;199:53-60.
- 2. Matheï C, Adriaensen W, Vaes B, et al. No relation between CMV infection and mortality in the oldest old: results from the Belfrail study. Age Ageing. 2015;44(1):130-135. doi: 10.1093/ageing/afu094.10.1093/ageing/afu09425026957
- 3. Michael J. Cannon, D. Schmid S, et al. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Reviews in Medical Virology. 2010;20 (4):202-213.10.1002/rmv.65520564615
- 4. Feinstein L, Douglas CE, Stebbins RC, et al. Does cytomegalovirus infection contribute to socioeconomic disparities in all-cause mortality? Mech Ageing Dev. 2016;158:53-61. doi:10.1016/j.mad.2016.06.00110.1016/j.mad.2016.06.001501820627268074
- 5. Stowe RP, Kozlova EV, Yetman DL, et al. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol. 2007;42:563-570.10.1016/j.exger.2007.01.005199244117337145
- 6. Aiello AE, Haan MN, Blythe L, et al. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc. 2006;54:1046-1054. doi: 10.1111/j.1532-5415.2006.00796.x.10.1111/j.1532-5415.2006.00796.x16866674
- 7. Schmaltz HN, Fried LP, Xue QL, et al. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc. 2005;53(5):747-754.10.1111/j.1532-5415.2005.53250.x15877548
- 8. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-M156.10.1093/gerona/56.3.M14611253156
- 9. Simanek AM, Dowd JB, Aiello AE. Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. Int J Epidemiol. 2009;38(3):775–787.10.1093/ije/dyn273268939419109247
- 10. Samanta M, Harkins L, Klemm K, et al. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol. 2003;170(3):998–1002.10.1097/01.ju.0000080263.46164.9712913758
- 11. Savva GM, Pachnio A, Kaul B, et al. Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell. 2013;12(3):381-7.10.1111/acel.1205923442093
- 12. Khan N, Hislop A, Gudgeon N, et al. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol. 2004;173:7481-7489.10.4049/jimmunol.173.12.748115585874
- 13. Vescovini R, Telera A, Fagnoni FF, et al. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells. Exp Gerontol. 2004;39:1233-1243.10.1016/j.exger.2004.04.00415288697
- 14. Zaia JA, Gallez-Hawkins GM, Tegtmeier BR, et al. Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma, J Infect Dis. 1997; 176: 782-785.
- 15. Wang GC, Kao WHL, Murakami P, et al. Cytomegalovirus Infection and the Risk of Mortality and Frailty in Older Women: A Prospective Observational Cohort Study. American Journal of Epidemiology. 2010;171(10):1144-1152.10.1093/aje/kwq062287747020400465
- 16. Lopo S, Vinagre E, Palminha P, et al. Seroprevalence to cytomegalovirus in the Portuguese population, 2002–2003. Euro Surveill. 2011;16(25). pii: 19896.10.2807/ese.16.25.19896-en
- 17. Olsson J, Kok E, Adolfsson R, et al. Herpes virus seroepidemiology in the adult Swedish population. Immun Ageing. 2017;14:10 10.1186/s12979-017-0093-410.1186/s12979-017-0093-4542439328491117
- 18. Antona D, Lepoutre A, Fonteneau L, et al. Seroprevalence of cytomegalovirus infection in France in 2010. Epidemiol Infect. 2017;45(7):1471-1478. doi: 10.1017/S095026881700010310.1017/S095026881700010328166842
- 19. Pawelec G, McElhaney JE, Aiello AE, et al. The impact of CMV infection on survival in older humans. Curr Opin Immunol. 2012;24:507-511.10.1016/j.coi.2012.04.00222541724
- 20. Staras SA, Dollard SC, Radford KW, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis. 2006;43:1143–1151.10.1086/50817317029132
- 21. Krmpotić A, Podlech J, Reddehase MJ, et al. Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades’ résumé. Med Microbiol Immunol 2019;208:415-429. https://doi.org/10.1007/s00430-019-00600-110.1007/s00430-019-00600-1670560830923898